Strategy for Prompt and Effective Thoracentesis in the Emergency Department
SPEEDTAP
1 other identifier
interventional
188
1 country
6
Brief Summary
The SPEEDTAP-trial is a prospective, randomised, investigator-initiated, multicenter, clinical superior trial investigating two thoracentesis methods in four emergency departments (ED) in Central Denmark Region. Patients are randomised to either manual fluid removal in the ED or passively fluid drainage using gravity in the radiology department (standard of care). Primary outcome: time from clinical indication to complete drainage and 188 patients will be included. Key secondary outcomes include length of stay, ED admission to ED discharge and safety end-points.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2024
Typical duration for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 9, 2023
CompletedFirst Posted
Study publicly available on registry
December 22, 2023
CompletedStudy Start
First participant enrolled
January 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedDecember 5, 2024
December 1, 2024
1.9 years
November 9, 2023
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time from identification of the clinical indication for thoracentesis to complete drainage
Time from identification of the clinical indication for thoracentesis is defined as the time patient is randomized. The time of complete drainage is defined by removal of pigtail catheter
From date and time for randomization until the date and time removal of catheter, assessed up to 3 month
Secondary Outcomes (10)
Hospital length of stay (days)
Date of admission until date of hospital discharge, assessed up until 3 month
Duration of procedure (time)
from date and time for insertion until date and time for removal, assessed up until 3 month
Patients degree of chest discomfort (score)
from date of indication until removal of catheter, assessed up until 3 month
Patients degree of breathlessnesss (score)
from date of indication until removal of catheter, assessed up until 3 month
Patients satisfaction
On the date of removal, assessed up until 1 month
- +5 more secondary outcomes
Study Arms (2)
Control group
ACTIVE COMPARATORStandard of care thoracentesis in the radiology department ( passively drainage using gravity)
Intervention group
EXPERIMENTALThoracentesis in the emergency department (manual fluid drainage using a syringe connected to a three-way stopcock)
Interventions
Patients will be referred to the radiology department. Thoracentesis will be performed according to local guidelines.
Thoracentesis will be performed according to current guidelines in the emergency department. Fluid will manually be drained using a syringe connected to a three-way stopcock. Thoracentesis will be stopped early if:
Eligibility Criteria
You may qualify if:
- Patients ≥ 18 years admitted to the ED
- Pleural effusion detected by any imaging modality (e.g., bedside ultrasound, chest x-ray, computed tomography)
- Clinically justified need for thoracentesis ( symptomatic relief and/or define the etiology of the effusion
- Without contraindication for thoracentesis in the emergency department (e.g., anticoagulant treatment)
You may not qualify if:
- Life-threatening respiratory distress
- Not able to give consent
- Previous pleurodesis
- Effusion does not appear free-flowing due to septations or loculations / suspected empyema
- Prior enrollment in the trial
- If randomization is not possible because decision to insert a pigtail catheter is made in the radiology department
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Aarhuslead
- Central Denmark Regioncollaborator
Study Sites (6)
Aarhus University Hospital
Aarhus, Central Jutland, 8200, Denmark
Gødstrup Regional Hospital
Gødstrup, Central Jutland, 7400, Denmark
Horsens Regional Hospital
Horsens, Central Jutland, 8700, Denmark
Randers Regional Hospital
Randers, Central Jutland, 8930, Denmark
Aalborg University Hospital
Aalborg, North Denmark, Denmark
Esbjerg sygehus
Esbjerg, South Region Denmark, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sandra T Langsted
Aarhus University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2023
First Posted
December 22, 2023
Study Start
January 15, 2024
Primary Completion
November 30, 2025
Study Completion
December 31, 2025
Last Updated
December 5, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will share
- Time Frame
- Six months after the publication of the last results, all de-identified individual patient data will be made available upon request. There will be no predetermined end date for the data sharing.
De-identified data necessary to reproduce published results will be made available on reasonable requests.